Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bayer CropScience and Precision BioSciences Inc., a biotechnology company headquartered in Research Triangle Park, NC, USA, announced that they have entered into a collaborative agreement to create site–specific genome modifications in plants. The agreement provides Bayer CropScience with non–exclusive access to aspects of Precision BioSciences’ proprietary Directed Nuclease Edito technology, which can be used to develop novel traits in plants.

Today in Biotechnology...keeping you current

Safety First in Biotech Development
BioPharm, 12/03/09

Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09

Complete Genomics and GATC Biotech Collaborate on Human Genome Sequencing Projects
b3c newswire, 12/02/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address